All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for NOVAVAX, INC. · biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate · $50,000.00 income · posted Apr 21, 2025

Official filing document

Bills named in this filing 2

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…

Lobbying activity 3

Health Issues

Issues related to COVID-19 vaccines. Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers. General discussions related to vaccine injury compensation programs and vaccine strain selection timelines.

Budget/Appropriations

H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4); H.Con.Res.14, FY2025 Budget Resolution; FY2025 Budget Reconciliation Process; all bio-pharmaceutical related provisions.

Trade (domestic/foreign)

Issues related to tariffs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.